A recent report by BCC Research forecasts that the global demand for immunoassays will see continuous growth worldwide over the next five years. According to the study, the global demand for immunoassay testing is expected to register a five-year compound annual growth rate (CAGR) of 4.7%, with the potential to reach nearly $21 billion by 2017. BCC Research estimates the highest opportunities of growth in the immunoassay market exist in the Asian region, followed by Europe, the Middle East and Africa.
The development of new applications is an important factor contributing to these trends. The aging population and the demand for more sophisticated and longer-term healthcare have led to the need for advanced medical electronic devices including immunoassay systems. The rise in the number of medical establishments like hospitals and clinics is driving the demand for precise, timely and cost-effective laboratory tests. Immunoassay systems that can help labs meet their goals should offer more simplified operation while enabling efficient and economical high volume testing.
Beckman Coulter’s UniCel DxI 800 Access is a quality immunoassay system that meets all these requirements. It is specifically designed to simplify and automate immunoassay testing with excellent throughput, proven chemiluminescent technology, assay protocols. It offers
- Loading of reagents and all consumables ‘on-the-fly’
- Load capacity of 120 samples at once
- 400 tests per hour
- Intuitive operator interface with touch screen capability
- Compatibility across multiple systems
- Onboard capacity of 50 refrigerated reagent packs for enhanced flexibility
- Simplified inventory management
The UniCel DxI 800 Access extends walkaway capacity with its high volume capacity. This innovative immunoassay system is available re-certified with 90 day parts warranty.